News

Schlieren/San Francisco - VirtaMed has agreed a partnership with the medtech firm Andromeda Surgical, which specializes in the area of surgical robots. The new partners will now seek to drive the adoption of surgical robotics on the basis of digital twins.

Basel/Zurich - Roche, the University of Zurich (UZH) and the University Hospital Zurich (USZ) have signed a research collaboration agreement to investigate the use of Real World Data. Initially, the project will focus on health data from oncology patients.

Volketswil - The software company Klepsydra AI and Frontgrade Gaisler from Gothenburg have announced a collaboration to adapt the microprocessors used in space missions. The initiative is part of a contract awarded by the European Space Agency (ESA).

The Greater Zurich Area is a vibrant hub for the cleantech sector, underpinned by the Swiss people's commitment to sustainability and environmental innovation. The nation's advanced environmental policies, like the Swiss Energy Strategy 2050, draw significant investment in green technologies. Despite its small size, the Greater Zurich Area's focus on precision and high-quality solutions makes it a standout in the cleantech sector.

Schlieren/Bagsværd - EraCal Therapeutics has granted the rights to its oral program for controlling appetite and obesity to Danish pharma producer Novo Nordisk. The agreement provides for payments of up to €235 million, plus royalties on sales of a marketed product.

Dübendorf/Raleigh - The North American venture capital firm Dental Innovation Alliance has made a fifth investment in Odne. This will support the market launch of an innovative root canal treatment, which Odne plans to bring to market in the second quarter of 2024.

Zurich - Researchers from the Swiss Federal Institute of Technology in Zurich (ETH) have developed a navigation system that helps to avoid supply chain bottlenecks for medication. They have shown that supply chains are more resilient depending on how flexibly wholesalers can switch to alternative distribution channels.

Schlieren/Cologne - DISCO Pharmaceuticals has secured seed funding of 20 million euros and officially launched the business. The team has successfully mapped the organization of proteins on the surface of a type of cancer cell for the first time. The pipeline also includes other cancer indications, thereby providing urgently needed new target molecules for cancer therapies.

Zurich/Davos - The Federal Department of Foreign Affairs and the Swiss Federal Institute of Technology in Zurich have launched the International Computation and AI Network. The aim of the network of supercomputers working with artificial intelligence (AI) is to implement UN goals and global sustainability.